Craft

Guided Therapeutics

Stock Price

$0.2

2024-10-29

Market Capitalization

$12 M

2024-10-28

Revenue

$767 K

FY, 2025

Guided Therapeutics Summary

Company Summary

Overview
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices to enhance healthcare. Its technology, including products in research and development, primarily relates to biophotonics technology for the non-invasive detection of cancers. The company is developing LuViva, a non-invasive cervical cancer detection device; and extension of its cancer detection technology into other cancers, primarily esophageal. The company’s LuViva device would identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.
Type
Public
Status
Active
Founded
1992
HQ
Peachtree Corners, GA, US | view all locations
Website
http://www.guidedinc.com/
Cybersecurity rating
Sectors

Key People

  • Gene Cartwright

    Gene Cartwright, Chief Executive Officer and Director

    • Mark L. Faupel

      Mark L. Faupel, Chief Operating Officer and Director

      • Richard L. Fowler

        Richard L. Fowler, Sr. Vice-President, Engineering

        LocationsView all

        1 location detected

        • Peachtree Corners, GA HQ

          United States

          5835 Peachtree Corners E

        Guided Therapeutics Financials

        Summary Financials

        Net income (Q1, 2026)
        ($500.0K)
        Cash (Q1, 2026)
        $369.0K
        EBIT (Q1, 2026)
        ($302.0K)
        Enterprise value
        $13.0M

        Footer menu